Labcorp enters into strategic relationship with Prisma Health

BURLINGTON, N.C. --(BUSINESS WIRE)--Mar. 9, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, is entering into a strategic laboratory relationship with Prisma Health , a nonprofit and the largest health system in South Carolina.

Walgreens and Labcorp offer at-home COVID-19 PCR test collection kits at no cost nationwide

Collaboration expands access to convenient testing at no cost for eligible individuals DEERFIELD, Ill., and BURLINGTON, N.C., March 7, 2022 – Walgreens and Labcorp, a leading global life sciences company, today announced the nationwide [i] availability of Pixel by Labcorp® [ii] COVID-19 at-home collection kit, a PCR test available through Labcorp OnDemand™, at no cost to individuals who meet clinical guidelines*.

Detecting measurable residual disease (MRD) in hematological malignancies using flow cytometry

A patient may be in complete remission during or after a cancer treatment, but a few cancer cells may persist in what is known as residual disease. To better inform prognoses, understand treatment decisions, predict a patient’s overall survival or understand the potential for disease relapse, it is important to have the ability to detect and quantify these malignant cells.